What is CHAARM
CHAARM
Combined Highly Active
Anti-Retroviral Microbicides
CHAARM is a large scale collaborative project 
co-funded by the European Commission under 
the 7th Framework Programme (FP7) 
for Research and Technological Development 

aimed at developing existing 
and new microbicides as 
topical agents, to reduce 
transmission of HIV

Duration: 
01/01/2010 – 31/12/2014

Total budget: 17 m €

Microbicides
Microbicides are compound that could be applied in the form of a gel, cream or a slow-release device so as to prevent infection with HIV at vaginal or rectal surfaces.

No microbicide has yet been approved for use although a number are being tested in clinical trials.
 
CHAARM develops new microbicides aimed at both established and new targets so as to help maintain a pipeline of promising candidates and will also develop combinations of microbicides.
 
Combining 2 or more microbicides in a single product may be much more effective than using a single microbicide and, importantly, may reduce the
likelihood of HIV becoming resistant to the product.

That is what CHAARM is aimed at.
PRESS
MICROBICIDES
preventing
HIV transmission
CHAARM project 
involves scientists with expertise in a wide range of different disciplines bringing together 31 institutions (Universities, Research Institutes, SMEs and larger industries in microbicides) in 12 countries, including 8 EU Member States, as well as Switzerland,Ukraine, South Africa and the United States of America.